Tarsus Pharmaceuticals, Inc. (TARS)
75.69
-0.27
(-0.36%)
USD |
NASDAQ |
Sep 25, 16:00
75.66
-0.02
(-0.03%)
After-Hours: 19:59
Tarsus Pharmaceuticals Market Cap : 3.275B for Sept. 25, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 25, 2026 | 3.275B |
| September 24, 2026 | 3.287B |
| September 23, 2026 | 3.215B |
| September 22, 2026 | 3.335B |
| September 21, 2026 | 3.352B |
| September 18, 2026 | 3.379B |
| September 17, 2026 | 3.420B |
| September 16, 2026 | 3.360B |
| September 15, 2026 | 3.385B |
| September 14, 2026 | 3.460B |
| September 11, 2026 | 3.432B |
| September 10, 2026 | 3.510B |
| September 09, 2026 | 3.582B |
| September 08, 2026 | 3.774B |
| September 04, 2026 | 3.928B |
| September 03, 2026 | 3.600B |
| September 02, 2026 | 3.581B |
| September 01, 2026 | 3.204B |
| August 31, 2026 | 3.212B |
| August 28, 2026 | 3.105B |
| August 27, 2026 | 3.112B |
| August 26, 2026 | 3.057B |
| August 25, 2026 | 3.092B |
| August 24, 2026 | 3.151B |
| August 21, 2026 | 3.146B |
| Date | Value |
|---|---|
| August 20, 2026 | 3.093B |
| August 19, 2026 | 3.178B |
| August 18, 2026 | 3.074B |
| August 17, 2026 | 3.056B |
| August 14, 2026 | 2.994B |
| August 13, 2026 | 2.981B |
| August 12, 2026 | 3.030B |
| August 11, 2026 | 3.006B |
| August 10, 2026 | 2.932B |
| August 07, 2026 | 2.804B |
| August 06, 2026 | 2.827B |
| August 05, 2026 | 2.652B |
| August 04, 2026 | 2.644B |
| August 03, 2026 | 2.638B |
| July 31, 2026 | 2.540B |
| July 30, 2026 | 2.561B |
| July 29, 2026 | 2.518B |
| July 28, 2026 | 2.536B |
| July 27, 2026 | 2.586B |
| July 24, 2026 | 2.524B |
| July 23, 2026 | 2.520B |
| July 22, 2026 | 2.477B |
| July 21, 2026 | 2.463B |
| July 20, 2026 | 2.420B |
| July 17, 2026 | 2.575B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Bristol Myers Squibb Co. | 128.42B |
| ANI Pharmaceuticals, Inc. | 1.700B |
| Corcept Therapeutics, Inc. | 12.53B |
| Veru, Inc. | 43.31M |
| Johnson & Johnson | 653.16B |
Market Cap Related Metrics
| PS Ratio | 5.360 |
| Price to Book Value | 9.446 |
| Price to Free Cash Flow | 58.03 |
| Price | 75.69 |
| Earnings Yield | -1.43% |